AU Patent

AU2012351805B2 — Samidorphan (ALKS 33) in combination with opioid agonists

Assigned to Alkermes Pharma Ireland Ltd · Expires 2016-04-21 · 10y expired

What this patent protects

The invention relates a composition comprising an opioid agonist and Compound- 1 : Compound- 1.

USPTO Abstract

The invention relates a composition comprising an opioid agonist and Compound- 1 : Compound- 1.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012351805B2
Jurisdiction
AU
Classification
—
Expires
2016-04-21
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.